AlphaStocks
5.4
Consider Buy

Elevance Health, Inc. (ELV)

Health Care / Managed Health Care

S&P 500

$382.83

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

#402out of 1123 in Health Care

Is Elevance Health, Inc. a Good Investment in 2026?

Elevance Health, Inc. (ELV) scores 5.4 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Elevance Health, Inc. as Attractive (6/9). However, the Graham model rates it Caution — 25% above fair value. Elevance Health, Inc. currently trades below its estimated fair value of $437, suggesting potential upside. Elevance Health, Inc. ranks #402 out of 1123 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E15.2ROE12.9Market Cap84BDiv Yield1.7

Estimated Fair Value

$437.1112% below

Trading near or slightly below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

25% above fair value

Lynch

Neutral

PEG 1.5 · Stalwart

Greenblatt

Attractive

Top half (rank 38%)

Frequently Asked Questions

Is Elevance Health, Inc. (ELV) a good investment?
Based on AlphaStocks' composite analysis, Elevance Health, Inc. (ELV) scores 5.4 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Trading near or slightly below estimated fair value.
What is Elevance Health, Inc.'s Piotroski F-Score?
Elevance Health, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ELV overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $437, ELV appears undervalued. The stock currently trades 12% below its estimated fair value. Trading near or slightly below estimated fair value.
How does ELV compare to other Health Care stocks?
Elevance Health, Inc. ranks #402 out of 1123 stocks in the Health Care sector, placing it in the top 36% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about ELV?
AlphaStocks evaluates ELV using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 5.4/10.

Similar Stocks

PARRBFAMNTAP

Compare ELV with

ELV vs PARRELV vs BFAMELV vs NTAP

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer